AMP-activated protein kinase as a key molecular link between metabolism and clockwork

Experimental and Molecular Medicine

Volumn 45, Issue 7, 2013, Pages

  Lee, Yongjin ^a   Kim, Eun Kyoung ^a  

^a Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

Author keywords

AMPK; Circadian clock; CKI; CRY; Metabolism; SIRT1

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; CASEIN KINASE I; CRYPTOCHROME; CRYPTOCHROME 1; CRYPTOCHROME 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PALMITIC ACID; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; SIRTUIN 1; TRANSCRIPTION FACTOR CLOCK; SIRTUIN;

BMAL1 GENE; CIRCADIAN RHYTHM; CLOCK GENE; CRY1 GENE; CRY2 GENE; ENERGY BALANCE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; GENE; GENE EXPRESSION REGULATION; HUMAN; INTRACELLULAR SIGNALING; METABOLIC DISORDER; METABOLIC REGULATION; METABOLISM; MOLECULAR CLOCK; MOLECULAR INTERACTION; MOLECULAR SENSOR; NEUROMODULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PER1 GENE; PER2 GENE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; ANIMAL;

MAMMALIA;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CASEIN KINASE I; CIRCADIAN CLOCKS; CRYPTOCHROMES; HUMANS; METABOLISM; SIRTUINS;

EID: 84882966981     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2013.65     Document Type: Review

References (78)

1. Panda S, Hogenesch JB, Kay SA. Circadian rhythms from flies to human. Nature 2002;417:329-335.
2. Schibler U. The daily rhythms of genes, cells and organs. Biological clocks and circadian timing in cells. EMBO Rep 2005;6:S9-13.
3. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002;408:935-941.
4. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003;4:649-661.
5. Green CB, Takahashi JS, Bass J. The meter of metabolism. Cell 2008;134:728-742.
6. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. Posttranslational mechanisms regulate the mammalian circadian clock. Cell 2001;107:855-867.
7. Lowrey PL, Takahashi JS. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet 2004;5:407-441.
8. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U et al. The orphan nuclear receptor REV-ERB α controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002;110:251-260.
9. Guillaumond F, Dardente H, Giguère V, Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 2005;20:391-403.
10. Crumbley C, Burris TP. Direct regulation of clock expression by REV-ERB. PLoS One 2011;6:e17290.
11. Lee Y, Chen R, Lee HM, Lee C. Stoichiometric relationship among clock proteins determines robustness of circadian rhythms. J Biol Chem 2011;286:7033-7042.
12. Chen R, Schirmer A, Lee Y, Lee H, Kumar V, Yoo SH et al. Rhythmic PER abundance defines α critical nodal point for negative feedback within the circadian clock mechanism. Mol Cell 2009;36:417-430.
13. Sahar S, Sassone-Corsi P. Circadian rhythms and memory formation: regulation by chromatin remodeling. Front Mol Neurosci 2012;5:37.
14. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002;109:307-320.
15. Akhtar RA, Reddy AB, Maywood ES, Clayton JD, King VM, Smith AG et al. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr Biol 2002;12:540-550.
16. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007;8:774-785.
17. Corton JM, Gillespie JG, Hardie DG. Role of the AMP-activated protein kinase in the cellular stress response. Curr Biol 1994;4:315-324.
18. Crute BE, Seefeld K, Gamble J, Kemp BE, Witters LA. Functional domains of the α 1 catalytic subunit of the AMP-activated protein kinase. J Biol Chem 1998;273:35347-35354.
19. Hudson ER, Pan DA, James J, Lucocq JM, Hawley SA, Green KA et al. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Current Biol 2003;13:861-866.
20. Polekhina G, Gupta A, Michell BJ, Van Denderen B, Muvrthy S, Feil SC et al. AMPK β-Subunit targets metabolic stress-sensing to glycogen. Curr Biol 2003;13:867-871.
21. Bateman A. The structure of α domain common to archaebacteria and the homocystinuria disease protein. Trends Biochem Sci 1997;22:12-13.
22. Cheung P C F, Salt IP, Davies SP, Hardie DG, Carling D. Characterization of AMP-activatd protein kinase g-subunit isoforms and their role in AMP binding. Biochem J 2000;346:659-669.
23. Scott JW, Hawley SA, Green KA, Anis M, Stewart G, Scullion GA et al. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J Clin Invest 2004;113:274-284.
24. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004;117:5479-5487.
25. Witters LA, Kemp BE, Means AR. Chutes and Ladders: the search for protein kinases that act on AMPK. Trends Biochem Sci 2006;31:13.
26. Davies SP, Carling D, Munday MR, Hardie DG. Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Effects of high fat diets. Eur J Biochem 1992;203:615-623.
27. Scott JW, Norman DG, Hawley SA, Kontogiannis L, Hardie DG. Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and α model substrate. J Mol Biol 2002;317:309-323.
28. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS et al. AMPK phosphorylation of raptor mediates α metabolic checkpoint. Mol Cell 2008;30:214-226.
29. Bass J, Takahashi JS. Circadian integration of metabolism and energetic. Science 2010;330:1349-1354.
30. Lamia KA, Sachdeva UM, Di Tacchio L, Williams EC, Alvarez JG, Egan DF et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science 2009;326:437-440.
31. Siepka SM, Yoo SH, Park J, Song W, Kumar V, Hu Y et al. Circadian mutant overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell 2007;129:1011-1023.
32. Busino L, Bassermann F, Maiolica A, Lee C, Nolan PM, Godinho SI et al. SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science 2007;316:900-904.
33. Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev 2000;14:2950-2961.
34. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007;6:458-471.
35. Ma D, Panda S, Lin JD. Temporal orchestration of circadian autophagy rhythm by C/EBPbeta. EMBO J 2011;30:4642-4651.
36. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007;6:472-483.
37. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science 2005;308:1043-1045.
38. Vielhaber E, Eide E, Rivers A, Gao ZH, Virshup DM. Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I epsilon. Mol Cell Biol 2000;20:4888-4899.
39. Keesler GA, Camacho F, Guo Y, Virshup D, Mondadori C, Yao Z. Phosphorylation and destabilization of human period I clock protein by human casein kinase I epsilon. Neuroreport 2000;11:951-955.
40. Camacho F, Cilio M, Guo Y, Virshup DM, Patel K, Khorkova O et al. Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2. FEBS Lett 2001;489:159-165.
41. Akashi M, Tsuchiya Y, Yoshino T, Nishida E. Control of intracellular dynamics of mammalian period proteins by casein kinase I epsilon (CKIepsilon) and CKIdelta in cultured cells. Mol Cell Biol 2002;22:1693-1703.
42. Gallego M, Virshup DM. Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol 2007;8:139-148.
43. Blau J. PERspective on PER phosphorylation. Genes Dev 2008;22:1737-1740.
44. Kloss B, Price JL, Saez L, Blau J, Rothenfluh A, Wesley CS et al. The Drosophila clock gene double-time encodes α protein closely related to human casein kinase Iepsilon. Cell 1998;94:97-107.
45. Pulgar V, Tapia C, Vignolo P, Santos J, Sunkel CE, Allende CC et al. The recombinant alpha isoform of protein kinase CK1 from Xenopus laevis can phosphorylate tyrosine in synthetic substrates. Eur J Biochem 1996;242:519-528.
46. Graves PR, Roach PJ. Role of COOH-terminal phosphorylation in the regulation of casein kinase I delta. J Biol Chem 1995;270:21682-21694.
47. Cegielska A, Gietzen KF, Rivers A, Virshup DM. Autoinhibition of casein kinase I epsilon (CKI epsilon) is relieved by protein phosphatases and limited proteolysis. J Biol Chem 1998;273:1357-1364.
48. Lowrey PL, Shimomura K, Antoch MP, Yamazaki S, Zemenides PD, Ralph MR et al. Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science 2000;288:483-492.
49. Vanselow K, Vanselow JT, Westermark PO, Reischl S, Maier B, Korte T et al. Differential effects of PER2 phosphorylation: molecular basis for the human familial advanced sleep phase syndrome (FASPS). Genes Dev 2006;20:2660-2672.
50. Meng QJ, Logunova L, Maywood ES, Gallego M, Lebiecki J, Brown TM et al. Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron 2008;58:78-88.
51. Um JH, Yang S, Yamazaki S, Kang H, Viollet B, Foretz M et al. Activation of 5'-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIe)-dependent degradation of clock protein mPer2. J Biol Chem 2007;282:20794-20798.
52. Price JL, Blau J, Rothenfluh A, Abodeely M, Kloss B, Young MW. Doubletime is a novel Drosophila clock gene that regulates PERIOD protein accumulation. Cell 1998;94:83-95.
53. Rothenfluh A, Abodeely M, Young MW. Short-period mutations of per affect a double-time-dependent step in the Drosophila circadian clock. Curr Biol 2000;10:1399-1402.
54. Masri S, Sassone-Corsi P. Plasticity and specificity of the circadian epigenome. Nat Neurosci 2010;13:1324-1329.
55. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 2006;125:497-508.
56. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D et al. The NADp-dependent deacetylase SIRT1 modulates CLOCK mediated chromatin remodeling and circadian control. Cell 2008;134:329-340.
57. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008;134:317-328.
58. Sebastian C, Satterstrom KF, Haigis MC, Mostoslavsky R. From sirtuin biology to human diseases: an update. J Biol Chem 2012;287:42444.
59. Chalkiadaki A, Guarente L. Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat Rev Endocrinol 2012;8:287-296.
60. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC et al. AMPK regulates energy expenditure by modulating NADp metabolism and SIRT1 activity. Nature 2009;458:1056-1060.
61. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008;14:661-673.
62. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007;450:712-716.
63. Feige JN, Lagouge M, Canto C, Strehle A, Houten SM, Milne JC et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 2008;8:347-358.
64. Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J et al. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J Biol Chem 2004;279:19970-19976.
65. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B et al. AMPkinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004;428:569-574.
66. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS et al. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004;10:727-733.
67. Kohsaka A, Laposky AD, Ramsey KM, Estrada C, Joshu C, Kobayashi Y et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 2007;6:414-421.
68. Froy O. Metabolism and circadian rhythms-implications for obesity. Endocr Rev 2010;31:1-24.
69. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007;8:21-34.
70. Mulherin AJ, Oh AH, Kim H, Grieco A, Lauffer LM, Brubaker PL. Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell. Endocrinology 2011;152:4610-4619.
71. Foretz M, Hebrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest 2010;120:2355-2369.
72. Rutter J, Reick M, Wu LC, McKnight SL. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science 2001;293:510-514.
73. McNamara P, Seo SB, Rudic RD, Sehgal A, Chakravarti D, Fitz Gerald GA. Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 2001;105:877-889.
74. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH et al. Extensive and divergent circadian gene expression in liver and heart. Nature 2002;417:78-83.
75. Maemura K, Takeda N, Nagai R. Circadian rhythms in the CNS and peripheral clock disorders: role of the biological clock in cardiovascular diseases. J Pharmacol Sci 2007;103:134-138.
76. Castro RM, Barbosa AA, Pedrazzoli M, Tufik S. Casein kinase I epsilon (CKIvarepsilon) N408 allele is very rare in the Brazilian population and is not involved in susceptibility to circadian rhythm sleep disorders. Behav Brain Res 2008;193:156-157.
77. Vieira E, Nilsson EC, Nerstedt A, Ormestad M, Long YC, Garcia-Roves PM et al. Relationship between AMPK and the transcriptional balance of clockrelated genes in skeletal muscle. Am J Physiol Endocrinol Metab 2008;295:E1032-E1037.
78. Lee HM, Chen R, Kim H, Etchegaray JP, Weaver DR, Lee C. The period of the circadian oscillator is primarily determined by the balance between casein kinase 1 and protein phosphatase 1. Proc Natl Acad Sci USA 2011;108:16451-16456.